Premium
Infliximab‐ and methotrexate‐resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva ® )
Author(s) -
Thielen A.M.,
Barde C.,
Saurat J.H.
Publication year - 2006
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2006.07447.x
Subject(s) - efalizumab , psoriasis , infliximab , methotrexate , discontinuation , medicine , dermatology , tumor necrosis factor alpha , plaque psoriasis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom